|2011 CABA Investment, Innovation & Entrepreneurship Symposium (Oct. 8th)|
"Pharma Open Innovations: Opportunities for Investors and Entrepreneurs"
Presented by: Chinese-American BioMedical Association (CABA)
When: 1:00PM-9:00PM, Saturday, October 8, 2011
Where: The Doubletree Guest Suites, Boston MA, 400 Soldiers Field Road, Boston, MA 02134
Luke Li, Ph.D., Exec Director, Head of Global Biotherapeutic Technologies, Bio-Innovation, Pfizer
Sridaran Natesan, Ph.D., Scientific Site Head (R&D) at Sanofi-Aventis Cambridge and Head of External Innovation and Partnering for the US Northeast region
David Dalgarno, Ph.D., VP of Research Technologies, Ariad
Wei Li, Ph.D., Principal, Fidelity Bioscience Ventures
Gayathri Srinivasan, Ph.D., Licensing Officer, University of Massachusetts Medical School
Karen Wong, Partner, Wilson Sonsini Goodrich & Rosati LLP
Jean Qiu, Ph.D., Founder & CTO, Nexcelom Bioscience
"Simcere Night先声之夜" 6:30PM - 9:00PM
Evening Keynote: Peng Wang, Ph.D., CSO, Simcere Pharmaceutical Group （先声药业）
Admission: CABA, CAIPLA, OCEAN, ACMA, NECINA, 128CUTE members: FREE; Non-members: $20.
On-site membership registration to CABA available. ($20 annual membership fee due), you can also register online at www.cabaweb.org.
Parking Direction: Please enter the hotel parking garage from Storrow Drive. Parking is free.
Philip Zhang, Ph.D., J.D., email@example.com
Jinbo Lee, Ph.D., firstname.lastname@example.org
Zhihong Chen, Ph.D., email@example.com